tm logo
MINSAVAN
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 02 Apr 2024

Last Applicant/ Owned by

66 Hudson Boulevard East

New York

NY

10001-219

Serial Number

98212613 filed on 06th Oct 2023

Registration Number

N/A

Correspondent Address

Richard A. Friedman

Pfizer Inc.

66 Hudson Boulevard East

Legal-Trademark & Copyright

New York,NY 10001-2192

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

MINSAVAN

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; Vaccines for human use

Mark Details


Serial Number

No 98212613

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T444329

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
02th Apr 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06th Feb 2024PUBLISHED FOR OPPOSITION
06th Feb 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17th Jan 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28th Dec 2023APPROVED FOR PUB - PRINCIPAL REGISTER
27th Dec 2023ASSIGNED TO EXAMINER
21st Dec 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06th Oct 2023NEW APPLICATION ENTERED